Immix Biopharma (IMMX) Tax Provisions (2021 - 2025)
Quarterly results put Tax Provisions at $11266.0 for Q4 2025, up 4.46% from a year ago — trailing twelve months through Dec 2025 was $37724.0 (down 8.07% YoY), and the annual figure for FY2025 was $37724.0, down 8.07%.
Immix Biopharma has reported Tax Provisions over the past 5 years, most recently at $11266.0 for Q4 2025.
- Tax Provisions reached $11266.0 in Q4 2025 per IMMX's latest filing, up from $7722.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $11266.0 in Q4 2025 and bottomed at $1337.0 in Q3 2021.
- Median Tax Provisions over the past 5 years was $6578.0 (2023), compared with a mean of $6072.8.
- The largest annual shift saw Tax Provisions surged 307.12% in 2023 before it crashed 30.71% in 2025.
- Over 5 years, Tax Provisions stood at $1477.0 in 2021, then soared by 256.06% to $5259.0 in 2022, then surged by 53.81% to $8089.0 in 2023, then surged by 33.33% to $10785.0 in 2024, then grew by 4.46% to $11266.0 in 2025.
- Business Quant data shows Tax Provisions for IMMX at $11266.0 in Q4 2025, $7722.0 in Q3 2025, and $8914.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 216,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,266.00 |
| Sep 30, 2025 | 7,722.00 |
| Jun 30, 2025 | 8,914.00 |
| Mar 31, 2025 | 9,822.00 |
| Dec 31, 2024 | 10,785.00 |
| Sep 30, 2024 | 11,144.00 |
| Jun 30, 2024 | 10,269.00 |
| Mar 31, 2024 | 8,839.00 |
| Dec 31, 2023 | 8,089.00 |
| Sep 30, 2023 | 6,807.00 |
| Jun 30, 2023 | 6,349.00 |
| Mar 31, 2023 | 5,170.00 |
| Dec 31, 2022 | 5,259.00 |
| Sep 30, 2022 | 1,672.00 |
| Jun 30, 2022 | 1,715.00 |
| Mar 31, 2022 | 1,622.00 |
| Dec 31, 2021 | 1,477.00 |
| Sep 30, 2021 | 1,337.00 |
| Jun 30, 2021 | 1,608.00 |
| Mar 31, 2021 | 1,591.00 |